Claims for Patent: 5,876,988

Summary for Patent: 5,876,988

Title:	Selection marker gene free recombinant strains: method for obtaining them and the use of these strains
Abstract:	The present invention discloses a selection marker free system which can be used to introduce genetic modifications in bacteria, yeasts and fungi. The system can be employed to introduce or delete desired genes or DNA fragments in the genome of the indicated host species without leaving any undesired DNA i.e. the selection marker used for selection of transformants or other DNA used for cloning. In this way strains have been developed containing only desired genes introduced at desired chromosomal sites. Similarly, desired DNA fragments have been deleted or replaced at desired sites.
Inventor(s):	Selten; Gerardus Cornelius Maria (Berkel en Rodenrijs, NL), Swinkels; Bart Willem (Delft, NL), Van Gorcom; Robertus Franciscus Maria (Delft, NL)
Assignee:	Gist-brocades BV (Ma Delft, NL)
Application Number:	08/880,557
Patent Claims:	1. A method for obtaining a recombinant strain containing a desired DNA fragment and free of a selection marker, said method comprising the steps of: a) obtaining transformants of a bacterial, filamentous fungal or yeast host strain by introducing into said host strain a DNA molecule comprising a desired DNA fragment and an acetamidase gene that is the selection marker, wherein said acetamidase gene is dominant with respect to said host strain, b) selecting transformants containing said desired DNA fragment and said acetamidase gene by selecting for the presence of said acetamidase gene, c) culturing said selected transformants under condition effecting deletion of said acetamidase gene, and d) selecting a recombinant strain containing said desired DNA fragment in which said acetamidase gene has been deleted. 2. The method according to claim 1 wherein said desired DNA fragment comprises a DNA molecule selected from the group consisting of a gene, a cDNA molecule, a promoter sequence, a translation terminator sequence, a regulatory element sequence, an intron sequence, a recognition sequence for a DNA-binding protein, a translation-initiation site and a restriction site. 3. The method according to claim 1 wherein steps a) to d) are repeated on the recombinant strain obtained in step d), using either the same or a different desired DNA fragment. 4. The method according to claim 1 wherein the acetamidase gene is that of a fungal species. 5. The method according to claim 4 wherein said fungal species is an Aspergillus species. 6. The method of claim 1, wherein said host strain is a fungal species. 7. The method of claim 6, wherein said host strain is a filamentous fungal species. 8. The method of claim 7, where said host strain is an Aspergillus species. 9. The method according to claim 6, wherein the acetamidase gene is that of a fungal species. 10. The method according to claim 9, wherein the acetamidase gene is that of an Aspergillus species. 11. The method according to claim 7, wherein the acetamidase gene is that of a fungal species. 12. The method according to claim 11, wherein the acetamidase gene is that of an Aspergillus species. 13. The method according to claim 8, wherein the acetamidase gene is that of a fungal species. 14. The method according to claim 13, wherein the acetamidase gene is that of an Aspergillus species. 15. The method according to claim 6, wherein said desired DNA fragment comprises a DNA molecule selected from the group consisting of a gene, a cDNA molecule, a promoter sequence, a translation terminator sequence, a regulatory element sequence, an intron sequence, a recognition sequence for a DNA-binding protein, a translation-initiation site and a restriction site. 16. The method according to claim 7, wherein said desired DNA fragment comprises a DNA molecule selected from the group consisting of a gene, a cDNA molecule, a promoter sequence, a translation terminator sequence, a regulatory element sequence, an intron sequence, a recognition sequence for DNA-binding protein, a translation-initiation site and a restriction site. 17. The method according to claim 8, wherein said desired DNA fragment comprises a DNA molecule selected from the group consisting of a gene, a cDNA molecule, a promoter sequence, a translation terminator sequence, a regulatory element sequence, an intron sequence, a recognition sequence for a DNA-binding protein, a translation-initiation site and a restriction site. 18. The method according to claim 6, wherein steps a) to d) are repeated on the recombinant strain obtained in step d), using either the same or a different desired DNA fragment. 19. The method according to claim 7, wherein steps a) to d) are repeated on the recombinant strain obtained in step d), using either the same or a different desired DNA fragment. 20. The method according to claim 8, wherein steps a) to d) are repeated on the recombinant strain obtained in step d), using either the same or a different desired DNA fragment. 21. The method of claim 1, wherein said selection marker gene is flanked by nucleotide sequence repeats, and wherein deletion of the selection marker gene is effected by recombination between said repeats. 22. The method according to claim 21 wherein said flanking nucleotide sequence repeats consist of a nucleotide sequence contained in the DNA of said host strain. 23. The method of claim 21, wherein said host strain is a fungal species. 24. The method according to claim 23, wherein said flanking nucleotide sequence repeats consist of a nucleotide sequence contained in the DNA of said host strain. 25. The method of claim 23, wherein said host strain is a filamentous fungal species. 26. The method according to claim 25, wherein said flanking nucleotide sequence repeats consist of a nucleotide sequence contained in the DNA of said host strain. 27. The method of claim 25, where said host strain is an Aspergillus species. 28. The method according to claim 27, wherein said flanking nucleotide sequence repeats consist of a nucleotide sequence contained in the DNA of said host strain. 29. A method for introducing an alteration into a target DNA sequence contained in a bacterial, filamentous fungal or yeast host strain which method comprises: (a) obtaining transformants of said host strain by introducing into said host strain a vector comprising an acetamidase selection marker gene, flanked by nucleotide sequence repeats to form a marker cassette, wherein said repeats consist of a nucleotide sequence immediately 5' or a nucleotide sequence immediately 3' of said target DNA sequence; and further wherein when said flanking nucleotide sequence repeats consist of a nucleotide sequence 5' of said target DNA sequence, said vector further comprises, 3' of, and contiguous to, said marker cassette, an additional nucleotide sequence consisting of a nucleotide sequence 3' of said target DNA sequence; and wherein when said flanking nucleotide sequence repeats consist of a nucleotide sequence 3' of said target DNA sequence, said vector further comprises, 5' of, and contiguous to, said marker cassette, an additional nucleotide sequence consisting of a nucleotide sequence 5' of said target DNA sequence; (b) selecting transformants by selecting for the presence of said acetamidase marker gene; (c) culturing said selected transformants under condition effecting deletion of said acetamidase marker gene by recombination between said flanking nucleotide sequence repeats; and (d) selecting a recombinant strain with an alteration in said target DNA in which said acetamidase marker gene has been deleted from said recombinant strain. 30. The method of claim 29 wherein said acetamidase gene is that of a fungal species. 31. The method of claim 30 wherein the fungal species is an Aspergillus species.

Details for Patent 5,876,988

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2013-07-23
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2013-07-23
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2013-07-23